Paul Noble
Physician · Cedars-Sinai Medical Center
Credentials: · · · · ·
History
Present
- 1984–1987
Internal Medicine
Research
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
New England Journal of Medicine · 2014 · 3,674 citations
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
New England Journal of Medicine · 2014 · 3,144 citations
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
The Lancet · 2011 · First of 13 authors · Corresponding · 1,684 citations
22 papers
20 papers
17 papers
- SN
14 papers
- RH
13 papers
- SS
12 papers
12 papers
11 papers
Grants
- 2026–2031
Viral-Mediated Immunological Niche Facilitates Lung Fibrosis
National Heart, Lung, and Blood Institute · P01
Project lead · $462K · Cedars-Sinai Medical Center
- 2020–2027
Molecular Regulation of Progressive Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R35
Contact PI · $5.7M · Univ of North Carolina Chapel Hill
- 2022–2027
ZIP8-Dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis
National Institute on Aging · R01
PI · $2.7M · Cedars-Sinai Medical Center
- 2012–2024
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
National Heart, Lung, and Blood Institute · P01
Contact PI · $19.7M · Cedars-Sinai Medical Center